DIANA WOODEN: Open Payments
NPI 1912500604 · FRANKLIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,922 in 42 payments from 18 companies in 2025. Trend: 2023 $1,038 · 2024 $1,546 · 2025 $1,922
Food & beverage: $1,832Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $552 |
| Axsome Therapeutics, Inc. | 4 | $262 |
| Novo Nordisk Inc | 4 | $217 |
| Astellas Pharma US Inc | 4 | $184 |
| ABBVIE INC. | 3 | $144 |
| Biogen, Inc. | 1 | $124 |
| Kestra Medical Technology Services, Inc. | 1 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
Products named: BREZTRI, Auvelity, VRAYLAR, AIRSUPRA, Ozempic, ZURZUVAE, Veozah, Assure WCD.
Industry payments across KY — which companies pay providers there.
